BSE filing, NSE: ABSLAMC. Summary written from the filing by ALFA Finder's alert engine.
Aditya Birla Sun Life AMC Ltd: key numbers
- Share price
- ₹868.95
- Market cap
- ₹25,148 Cr
- Revenue (annual)
- ₹1,845 Cr
- Net profit (annual)
- ₹975.1 Cr
- P/E (TTM)
- 25.5×Sector 19.7×
- Promoter holding
- 74.67%-0.04% QoQ
- FII holding
- 4.32%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Aditya Birla Sun Life AMC Ltd
All →Aditya Birla Sun Life AMC Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹526 Cr (+4% YoY), PAT ₹221 Cr (-8% YoY); H1 revenue ₹1,152 Cr (+7%), PAT ₹530 Cr (+2%). Strategy: passives, SIF, alternates, EPFO/ESIC mandates, direct channel build.
Aditya Birla Sun Life AMC Q2 FY27 Results: Net Profit ₹221 Cr, Down 8.4% YoY
Aditya Birla Sun Life AMC Ltd reported revenue from operations of ₹483.8 Cr (+4.9% YoY) and net profit of ₹221 Cr (-8.4% YoY) for Q2 FY27.
- Key figure
- Net profit ₹221 Cr · -8.4% YoY
Aditya Birla Sun Life AMC Employee Stock Options
Aditya Birla Sun Life AMC Limited allotted 34,106 equity shares under its ESOP Scheme 2021. This allotment increases the company's paid-up equity share capital to Rs. 144.70 Crore.
Aditya Birla Sun Life AMC Board Meeting Date
Aditya Birla Sun Life AMC will hold a board meeting on October 21, 2026, to consider and approve its quarterly and half-yearly unaudited financial results.
Aditya Birla Sun Life AMC Other Announcement
Aditya Birla Sun Life AMC submitted the quarterly certificate under SEBI Regulation 74(5), confirming no securities were received for dematerialization or rematerialization during the period.
Aditya Birla Sun Life AMC Employee Stock Options
Aditya Birla Sun Life AMC allotted 16,637 equity shares under its 2021 ESOP scheme. This exercise marginally increases the company's total paid-up share capital.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.